Foulks M J
FamCare, Inc., Cumberland, New Jersey, USA.
J Obstet Gynecol Neonatal Nurs. 1998 Jul-Aug;27(4):367-73. doi: 10.1111/j.1552-6909.1998.tb02660.x.
Since the introduction of the Papanicolaou (Pap) smear in 1942, deaths from cervical cancer have decreased. The Healthy People 2000 objectives for women include a further decrease in the cervical cancer death rate and an increase in the number of women consistently receiving Pap smears. An overview of the life of Dr. Papanicolaou, the risk factors that have been established to determine Pap smear intervals, and improvements in managing results are presented. The false-negative Pap smear rate, reported at between 5% and 30%, may be a barrier to detection. To correct this, new regulations and new technology have been introduced. However, thousands of women have never received a Pap smear or receive it sporadically. To reduce deaths from cervical cancer, lowering the false-negative rate may not be as important as having regular Pap smears.
自1942年帕潘尼古拉乌（巴氏）涂片检查问世以来，宫颈癌死亡人数有所下降。《健康人民2000》针对女性设定的目标包括进一步降低宫颈癌死亡率以及增加持续接受巴氏涂片检查的女性人数。本文概述了帕潘尼古拉乌博士的生平、已确定的用于确定巴氏涂片检查间隔时间的风险因素以及检查结果管理方面的改进。据报道，巴氏涂片检查的假阴性率在5%至30%之间，这可能是检测的一个障碍。为纠正这一问题，已出台新规定和新技术。然而，成千上万的女性从未接受过巴氏涂片检查或只是偶尔接受检查。为降低宫颈癌死亡率，降低假阴性率可能不如定期进行巴氏涂片检查重要。
